Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium glucoheptonate is a mineral supplement used primarily to treat and prevent hypocalcemia, a condition characterized by abnormally low levels of calcium in the blood. It is also used as an antidote for magnesium toxicity and to neutralize certain toxins, such as those from hydrofluoric acid burns. The drug provides a bioavailable source of calcium ions, which are essential for bone health, muscle contraction, nerve function, blood coagulation, and various enzymatic processes. Calcium glucoheptonate is particularly valued for its superior solubility and bioavailability compared to other calcium salts like calcium carbonate. It is considered safe for use in children and pregnant women when administered appropriately[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium glucoheptonate.